AUROLABPharmaceuticals
Auro Laboratories Limited — PE Ratio & Valuation Analysis
₹265.00
-2.50%
Current P/E71.08xPrice to earnings
Industry P/E31.77xSector average
⚠️
123.7% Premium to Industry
AUROLAB P/E 71.08x vs sector avg 31.77x
💡
Understanding Auro Laboratories Limited Valuation
Auro Laboratories Limited (AUROLAB) currently trades at 71.08x earnings. The Pharmaceuticals sector average PE is 31.77x. AUROLAB commands a premium, reflecting high growth expectations. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
N/A
Dividend Yield
0.00%
More on Auro Laboratories Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.